Abstract
This study investigated the effects of fosinopril on the electrophysiological characteristics of the left ventricular hypertrophic myocardium in spontaneously hypertensive rats (SHRs). Twenty-four 10-week-old male SHRs were divided into fosinopril and non-fosinopril groups (n = 12 each). Twelve 10-week-old Wistar–Kyoto rats were used a control group. Left ventricular mass index and ventricular fibrillation threshold (VFT) were measured after 8 weeks of fosinopril or saline treatment. L-type calcium current (I CaL), sodium current (I Na), and transient outward potassium current (I to) were measured in left ventricular myocytes after 8 weeks of fosinopril or saline treatment using the whole-cell patch-clamp technique. VFT was higher in the fosinopril group than in the non-fosinopril group (17.5 ± 1.2 mA vs. 15.6 ± 1.1 mA, P < 0.01). The density of I CaL was lower in the fosinopril group than in the non-fosinopril group (−7.17 ± 0.13 pA/pF vs. −7.87 ± 0.13 pA/pF, P < 0.05). The density of I to was higher in the fosinopril group than in the non-fosinopril group (14.46 ± 0.28 pA/pF vs. 12.66 ± 0.25 pA/pF, P < 0.05). I to was positively correlated with VFT (r = 0.90, P < 0.001) and was found to be associated independently with VFT (P < 0.001). Fosinopril improves the electrophysiological characteristics of the left ventricular hypertrophic myocardium in SHRs.
Similar content being viewed by others
References
Ahmmed GU, Dong PH, Song G, Ball NA, Xu Y, Walsh RA, Chiamvimonvat N (2000) Changes in Ca(2+) cycling proteins underlie cardiac action potential prolongation in a pressure-overloaded guinea pig model with cardiac hypertrophy and failure. Circ Res 86(5):558–570
Cerbai E, Barbieri M, Mugelli A (1994) Characterization of the hyperpolarization-activated current, I(f), in ventricular myocytes isolated from hypertensive rats. J Physiol 481(Pt 3):585–591
Cerbai E, Crucitti A, Sartiani L, De Paoli P, Pino R, Rodriguez ML, Gensini G, Mugelli A (2000) Long-term treatment of spontaneously hypertensive rats with losartan and electrophysiological remodeling of cardiac myocytes. Cardiovasc Res 45(2):388–396
Chevalier B, Heudes D, Heymes C, Basset A, Dakhli T, Bansard Y, Jouquey S, Hamon G, Bruneval P, Swynghedauw B (1995) Trandolapril decreases prevalence of ventricular ectopic activity in middle-aged SHR. Circulation 92(7):1947–1953
Cutler MJ, Jeyaraj D, Rosenbaum DS (2011) Cardiac electrical remodeling in health and disease. Trends Pharmacol Sci 32(3):174–180
Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, März W, Wanner C (2011) Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 13(8):852–859
Galatius-Jensen S, Wroblewski H, Emmeluth C, Bie P, Haunsø S, Kastrup J (1996) Plasma endothelin in congestive heart failure: effect of the ACE inhibitor, fosinopril. Cardiovasc Res 32(6):1148–1154
Gómez AM, Valdivia HH, Cheng H, Lederer MR, Santana LF, Cannell MB, McCune SA, Altschuld RA, Lederer WJ (1997) Defective excitation-contraction coupling in experimental cardiac hypertrophy and heart failure. Science 276(5313):800–806
He BX, Yu GL, Liang XQ (2001) Effects of lorsartan, fosinopril on myocardial fibrosis, angiotensin II and cardiac remolding in hypertensive rats. Hunan Yi Ke Da Xue Xue Bao 26(2):118–120
Isenberg G, Klockner U (1982) Calcium tolerant ventricular myocytes prepared by preincubation in a “KB medium”. Pflugers Arch 395(1):6–18
Kääb S, Nuss HB, Chiamvimonvat N, O’Rourke B, Pak PH, Kass DA, Marban E, Tomaselli GF (1996) Ionic mechanism of action potential prolongation in ventricular myocytes from dogs with pacing-induced heart failure. Circ Res 78(2):262–273
Kurokawa S, Niwano S, Niwano H, Ishikawa S, Kishihara J, Aoyama Y, Kosukegawa T, Masaki Y, Izumi T (2011) Progression of ventricular remodeling and arrhythmia in the primary hyperoxidative state of glutathione-depleted rats. Circ J 75(6):1386–1393
Naggar I, Lazar J, Kamran H, Orman R, Stewart M (2014) Relation of autonomic and cardiac abnormalities to ventricular fibrillation in a rat model of epilepsy. Epilepsy Res 108(1):44–56
Okin PM, Bang CN, Wachtell K, Hille DA, Kjeldsen SE, Dahlöf B, Devereux RB (2013) Relationship of sudden cardiac death to new-onset atrial fibrillation in hypertensive patients with left ventricular hypertrophy. Circ Arrhythm Electrophysiol 6(2):243–251
Pahor M, Bernabei R, Sgadari A, Gambassi G Jr, Lo Giudice P, Pacifici L, Ramacci MT, Lagrasta C, Olivetti G, Carbonin P (1991) Enalapril prevents cardiac fibrosis and arrhythmias in hypertensive rats. Hypertension 18(2):148–157
Panikkath R, Reinier K, Uy-Evanado A, Teodorescu C, Gunson K, Jui J, Chugh SS (2013) Electrocardiographic predictors of sudden cardiac death in patients with left ventricular hypertrophy. Ann Noninvasive Electrocardiol 18(3):225–229
Raasch W, Bartels T, Schwartz C, Häuser W, Rütten H, Dominiak P (2002) Regression of ventricular and vascular hypertrophy: are there differences between structurally different angiotensin-converting enzyme inhibitors? J Hypertens 20(12):2495–2504
Sah R, Ramirez RJ, Oudit GY, Gidrewicz D, Trivieri MG, Zobel C, Backx PH (2003) Regulation of cardiac excitation-contraction coupling by action potential repolarization: role of the transient outward potassium current (I(to)). J Physiol 546(Pt 1):5–18
Shorofsky SR, Aggarwal R, Corretti M, Baffa JM, Strum JM, Al-Seikhan BA, Kobayashi YM, Jones LR, Wier WG, Balke CW (1999) Cellular mechanisms of altered contractility in the hypertrophied heart: big hearts, big sparks. Circ Res 84(4):424–434
Tomaselli GF (2010) Oxidant stress derails the cardiac connexon connection. J Clin Invest 120(1):87–89
Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, Kass D, Feldman AM, Marban E (1994) Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation 90(5):2534–2539
Tozakidou M, Goltz D, Hagenström T, Budack MK, Vitzthum H, Szlachta K, Bähring R, Ehmke H (2010) Molecular and functional remodeling of I(to) by angiotensin II in the mouse left ventricle. J Mol Cell Cardiol 48(1):140–151
Winter J, Brack KE, Coote JH, Ng GA (2014) Cardiac contractility modulation increases action potential duration dispersion and decreases ventricular fibrillation threshold via β1-adrenoceptor activation in the crystalloid perfused normal rabbit heart. Int J Cardiol 172(1):144–154
Yokoshiki H, Kohya T, Tomita F, Tohse N, Nakaya H, Kanno M, Kitabatake A (1997) Restoration of action potential duration and transient outward current by regression of left ventricular hypertrophy. J Mol Cell Cardiol 29(5):1331–1339
Yu G, Liang X, Xie X, Yang T, Sun M, Zhao S (2002) Apoptosis, myocardial fibrosis and angiotensin II in the left ventricle of hypertensive rats treated with fosinopril or losartan. Chin Med J (Engl) 115(9):1287–1291
Zhi-Bin H, Chang F, Mao-Huan L, Gui-Yi Y, Shu-Xian Z, Wei W. Effect of fosinopril on the transient outward potassium current of hypertrophied left ventricular myocardium in the spontaneously hypertensive rat. Naunyn Schmiedebergs Arch Pharmacol. 2014 Jan 19. [Epub ahead of print]
Acknowledgments
This study was supported by the Guangdong Province Science and Technology Project Plan and Social Development of China (No. 2010B031600060).
Conflicts of interest
None declared.
Author information
Authors and Affiliations
Corresponding author
Additional information
Zhi-Bin Huang and Chun-Yu Deng contributed equally to this study.
Rights and permissions
About this article
Cite this article
Huang, ZB., Deng, CY., Lin, MH. et al. Fosinopril improves the electrophysiological characteristics of left ventricular hypertrophic myocardium in spontaneously hypertensive rats. Naunyn-Schmiedeberg's Arch Pharmacol 387, 1037–1044 (2014). https://doi.org/10.1007/s00210-014-1024-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00210-014-1024-y